Renaissance Technologies’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,358
| Closed | -$41.7K | – | 4014 |
|
|
2024
Q2 | $41.7K | Buy |
17,358
+2,045
| +13% | +$7.24K | ﹤0.01% | 3310 |
|
|
2024
Q1 | $75K | Sell |
15,313
-6,287
| -29% | -$31.5K | ﹤0.01% | 3424 |
|
|
2023
Q4 | $90K | Buy |
21,600
+17,417
| +416% | +$131K | ﹤0.01% | 3330 |
|
|
2023
Q3 | $63K | Buy |
4,183
+588
| +16% | +$10.8K | ﹤0.01% | 3357 |
|
|
2023
Q2 | $105K | Sell |
3,595
-1,530
| -30% | -$47.3K | ﹤0.01% | 3458 |
|
|
2023
Q1 | $118K | Sell |
5,125
-1,438
| -22% | -$38.9K | ﹤0.01% | 3438 |
|
|
2022
Q4 | $95K | Sell |
6,563
-2,582
| -28% | -$49.8K | ﹤0.01% | 3639 |
|
|
2022
Q3 | $219K | Sell |
9,145
-2,752
| -23% | -$71K | ﹤0.01% | 3352 |
|
|
2022
Q2 | $236K | Buy |
11,897
+10,132
| +574% | +$225K | ﹤0.01% | 3575 |
|
|
2022
Q1 | $64K | Buy |
+1,765
| New | +$65.6K | ﹤0.01% | 3869 |
|
|
2021
Q4 | – | Sell |
-2,964
| Closed | -$211K | – | 4300 |
|
|
2021
Q3 | $211K | Sell |
2,964
-6,027
| -67% | -$686K | ﹤0.01% | 3187 |
|
|
2021
Q2 | $1.19M | Buy |
8,991
+2,529
| +39% | +$316K | ﹤0.01% | 2580 |
|
|
2021
Q1 | $866K | Sell |
6,462
-1,661
| -20% | -$210K | ﹤0.01% | 2667 |
|
|
2020
Q4 | $595K | Buy |
8,123
+6,175
| +317% | +$453K | ﹤0.01% | 2743 |
|
|
2020
Q3 | $148K | Sell |
1,948
-1,253
| -39% | -$84.2K | ﹤0.01% | 3163 |
|
|
2020
Q2 | $256K | Buy |
3,201
+1,322
| +70% | +$89.8K | ﹤0.01% | 3096 |
|
|
2020
Q1 | $77K | Buy |
1,879
+1,444
| +332% | +$110K | ﹤0.01% | 3271 |
|
|
2019
Q4 | $35K | Buy |
+435
| New | +$31.1K | ﹤0.01% | 3420 |
|
Other funds holding ASLN
Renaissance Technologies's ASLN Position: Q3 2024 in Review
Renaissance Technologies sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 17,358 shares — an estimated $41.7K sold.
Renaissance Technologies first reported a position in ASLN in Q4 2019 and held it in 18 quarters. The position peaked at $1.19M in Q2 2021. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.
- Renaissance Technologies reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Renaissance Technologies sold 17,358 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $41.7K.
- Renaissance Technologies first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 18 quarters.
- Renaissance Technologies's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $1.19M in Q2 2021.
- 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.